Wird geladen...
Non‐absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
BACKGROUND: Non‐absorbable disaccharides (lactulose and lactitol) are recommended as first‐line treatment for hepatic encephalopathy. The previous (second) version of this review included 10 randomised clinical trials (RCTs) evaluating non‐absorbable disaccharides versus placebo/no intervention and...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2016
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004252/ https://ncbi.nlm.nih.gov/pubmed/27153247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003044.pub4 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|